Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis
暂无分享,去创建一个
M. Hroch | S. Micuda | P. Nachtigal | M. Pericacho | H. Lastůvková | Jolana Schreiberova | K. Tripská | Fatemeh Alaei Faradonbeh | M. Kacerovský | Ivone Cristina Igreja Sá | S. Mičuda
[1] P. Hirsova,et al. Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats , 2022, Frontiers in Physiology.
[2] P. Pávek,et al. Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice. , 2021, Chemico-biological interactions.
[3] S. V. D. van de Graaf,et al. Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP. , 2021, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[4] M. Vinken,et al. Rodent models of cholestatic liver disease: A practical guide for translational research , 2021, Liver international : official journal of the International Association for the Study of the Liver.
[5] J. López-Novoa,et al. Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities , 2020, International journal of molecular sciences.
[6] Jinsong Gao,et al. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes and preeclampsia , 2020, Annals of translational medicine.
[7] R. Hyšpler,et al. Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver , 2020, International journal of molecular sciences.
[8] M. Vicen,et al. Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome , 2020, Cellular and Molecular Life Sciences.
[9] Na Yang,et al. ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] Li Chang‐qing,et al. mir‐22‐3p/KLF6/MMP14 axis in fibro‐adipogenic progenitors regulates fatty infiltration in muscle degeneration , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] H. Kay,et al. Labetalol-Induced Hepatotoxicity during Pregnancy: A Case Report , 2020, American Journal of Perinatology Reports.
[12] J. López-Novoa,et al. Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4 , 2020, Cells.
[13] E. Hadar,et al. Intrahepatic cholestasis of pregnancy as a risk factor for preeclampsia , 2020, Archives of Gynecology and Obstetrics.
[14] P. Malhotra,et al. Intestinal Absorption of Bile Acids in Health and Disease. , 2019, Comprehensive Physiology.
[15] R. Hyšpler,et al. High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice. , 2019, Life sciences.
[16] Anshul Gupta,et al. Descriptive Statistics and Normality Tests for Statistical Data , 2019, Annals of cardiac anaesthesia.
[17] Jingjing Cai,et al. The management of hypertension in women planning for pregnancy , 2018, British medical bulletin.
[18] C. Shim,et al. Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression , 2018, International journal of molecular sciences.
[19] J. D. Tebbens,et al. Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta. , 2018, Atherosclerosis.
[20] E. Cairrão,et al. Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal , 2018, Journal of cardiovascular development and disease.
[21] T. Smutny,et al. Iron depletion induces hepatic secretion of biliary lipids and glutathione in rats. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[22] G. Dekker,et al. A retrospective cohort review of intrahepatic cholestasis of pregnancy in a South Australian population. , 2017, European journal of obstetrics, gynecology, and reproductive biology.
[23] T. Firoz,et al. Drug-induced fulminant hepatic failure in pregnancy , 2015, Obstetric medicine.
[24] S. Maslovitz,et al. Severe intrahepatic cholestasis of pregnancy is a risk factor for preeclampsia in singleton and twin pregnancies. , 2015, American journal of obstetrics and gynecology.
[25] Huijun Sun,et al. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice , 2015, Pharmaceutical Research.
[26] R. Wong,et al. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis , 2015, Journal of cellular and molecular medicine.
[27] J. V. D. van der Post,et al. Total bile acids in the maternal and fetal compartment in relation to placental ABCG2 expression in preeclamptic pregnancies complicated by HELLP syndrome. , 2015, Biochimica et biophysica acta.
[28] V. Geenes,et al. Intrahepatic Cholestasis of Pregnancy , 2014, Obstetrics and gynecology.
[29] F. Blanco,et al. Oxysterol-Induced Soluble Endoglin Release and Its Involvement in Hypertension , 2012, Circulation.
[30] S. Tsuchida,et al. Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomy. , 2011, Journal of hepatology.
[31] R. Weiskirchen,et al. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. , 2011, Cellular signalling.
[32] J. López-Novoa,et al. The physiological role of endoglin in the cardiovascular system. , 2010, American journal of physiology. Heart and circulatory physiology.
[33] H. Verspaget,et al. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. , 2010, Cancer research.
[34] T. Libermann,et al. Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.
[35] J. Boyer,et al. Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.
[36] K. Aittomäki,et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: A population‐based study , 2006, Hepatology.
[37] D. Keppler,et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis , 2005, Hepatology.
[38] L. Mattsson,et al. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates , 2004, Hepatology.
[39] M. Anwer. Cellular regulation of hepatic bile acid transport in health and cholestasis , 2004, Hepatology.
[40] J. Boyer,et al. Bile salt transporters: molecular characterization, function, and regulation. , 2003, Physiological reviews.
[41] J. Marin,et al. Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism. , 2002, Clinical science.
[42] M. Letarte,et al. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. , 1994, Endocrinology.
[43] M. Letarte,et al. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. , 1990, The Journal of biological chemistry.
[44] T. Okuyama,et al. Protective effects of adrenoceptor-blocking agents on myocardial injury induced by epinephrine in mice. , 1990, The Journal of toxicological sciences.
[45] P. Ylöstalo,et al. CHANGES IN SERUM BILE ACID CONCENTRATIONS DURING NORMAL PREGNANCY, IN PATIENTS WITH INTRAHEPATIC CHOLESTASIS OF PREGNANCY AND IN PREGNANT WOMEN WITH ITCHING , 1981, British journal of obstetrics and gynaecology.
[46] D. Cova,et al. Effects of ethinyl estradiol on bile secretion and liver microsomal mixed function oxidase system in the mouse. , 1980, Biochemical pharmacology.